Vancouver, Canada On-site Full-time USD 52,500 – 62,300 / year

Xenon Pharmaceuticals is hiring a Discovery Operations Coordinator

Responsibilities

  • Offer administrative assistance to designated senior Discovery leaders, including managing calendars, travel plans, and expense claims.
  • Assist with on-site logistics for meetings and events, such as room preparation and catering coordination.
  • Oversee the intake, organization, and uploading of scientific data and reports from external vendors into the Electronic Lab Notebook and other corporate systems, ensuring data integrity, accuracy, traceability, and accessibility.
  • Coordinate data workflows to ensure timely delivery of externally produced data, reports, and outputs to relevant internal stakeholders.
  • Keep enterprise digital platforms updated with accurate and finalized information in compliance with organizational standards.
  • Evaluate, process, and archive Discovery-related reports and documentation to confirm completeness, consistency, and compliance before final release.
  • Work with scientific teams to maintain reliable records and inventory data across both physical and digital systems.
  • Partner with IT, research, and operations groups to support data integration, system processes, and workflow enhancements.
  • Support project coordination tasks such as scheduling meetings, organizing logistics, and monitoring routine project milestones and deliverables.
  • Promote a safe, orderly, and compliant work environment by following Health & Safety protocols.
  • Uphold company policies, including the Code of Business Conduct and Ethics, and ensure compliance among direct reports when applicable.
  • Perform additional duties as needed.

Benefits

  • Base salary
  • Targeted bonus opportunity
  • Stock options
  • Medical, dental, and vision insurance coverage
  • Short- and long-term disability protection
  • Accidental death and dismemberment insurance
  • Life insurance
  • Employee Assistance Program
  • Travel insurance
  • Retirement savings plan with employer matching

Compensation

Base salary, target bonus, stock options

Work Arrangement

On-site — Vancouver, BC, Canada

Team

Reports to Manager, Discovery Operations

Other

  • This role is based on-site with up to five days per week required in the office.
  • Position level will be determined by the candidate's education and relevant industry experience.
  • Adherence to Health & Safety policies and procedures is mandatory.
  • Compliance with company policies, including the Code of Business Conduct and Ethics, is required.
  • Paid time off includes vacation, personal days, sick days, and a company-wide shutdown at year-end.
  • Professional growth is supported through Training, Learning & Development initiatives and tuition assistance for advanced degrees.

Not specified

About company
Xenon Pharmaceuticals
Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team. We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting, and continue to advance an early-stage pipeline of novel therapeutic candidates. In 2025, we initiated Phase 1 trials for XEN1701 (targeting Nav1.7) and XEN1120 (targeting Kv7). Nav1.7 and Kv7 are important pain targets, and data from these Phase 1 studies are expected in 2026 to support Phase 2 proof-of-concept studies in acute pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
All jobs at Xenon Pharmaceuticals Visit website
Job Details
Department Discovery Program Management
Category other
Posted 9 days ago